The 12-month price targets, analyzed by analysts, offer insights with an average target of $505.0, a high estimate of $529.00 ...

Shares of Elevance Health Inc. ELV slipped 1.77% to $377.05 Monday, on what proved to be an all-around favorable trading ...

Barclays analyst Andrew Mok lowered Elevance Health’s price target to $480 from $522 but kept the “Overweight” rating. This ...